$QNT

Quantinuum Latest Results: Sales guidance beats estimates

Quantinuum (NASDAQ: QNT) updated FY2026 sales guidance to $28.0 million to $32.0 million, above the $26.485 million analyst consensus. The company also reported Q2 revenue of $8.0 million versus $7.598 million estimated, while adjusted EPS was $(0.28) versus $(0.26). Investors will watch revenue momentum versus cost pressure.

Original reporting
Published Aug 11, 2026, 9:48 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 8:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Quantinuum Latest Results: Sales guidance beats estimates — source image
Decision brief

The 30-second read

$QNTBullishMed
01

Why it matters

For trading, the key decision point is whether the market reprices the stock on stronger revenue visibility or sells the news due to ongoing cost pressure reflected in the EPS miss.

02

Market read

A concrete FY2026 sales guidance beat versus consensus is the primary catalyst, partially offset by an adjusted EPS miss that keeps margin risk alive.

03

What to watch

The guidance range ($28.0M-$32.0M) implies uncertainty; traders may wait for margin commentary or additional contract details not provided here.

Relevance 8/10Novelty 6/10Timing: after-hours/next-session positioning following FY2026 sales guidance update

Background

The article frames Quantinuum’s FY2026 outlook as improving commercialization traction, citing a sales guidance beat and mixed quarterly profitability.

Company-level read

Ticker impact

$QNTBullishMedium confidence
Context

Quantinuum guided FY2026 sales to $28.0M-$32.0M, above the $26.485M consensus, signaling stronger revenue visibility than expected.

Expected impact

Bias modestly upward for the next few sessions, with follow-through dependent on whether investors focus on sales momentum versus cost pressure.

Evidence & confidence

The text provides explicit FY2026 sales guidance versus consensus and also reports mixed Q2 results (sales beat, adjusted EPS miss), which typically creates a split reaction.

Market effects

Supports the narrative that quantum computing commercialization is progressing, though profitability remains a key gating factor.

No clear regional linkage beyond US-listed tech/quantum sentiment.

Limited, as the article does not cite major international contracts or regulatory actions.

Counterpoint

Investors may discount the sales beat if higher operating costs persist, since the article highlights an adjusted EPS miss alongside revenue growth.

Key entities

  • Quantinuum

    Quantum computing company providing updated FY2026 sales guidance and reporting mixed Q2 results.

  • FY2026 sales guidance

    Projected sales range of $28.0M to $32.0M versus $26.485M consensus estimate.

  • Adjusted EPS

    Reported adjusted EPS of $(0.28) versus $(0.26) estimate in the cited quarter.

Related articles

$ORCLMed

Quantinuum and Oracle bring Helios to OCI

Quantinuum and Oracle announced a multi-year partnership to bring Quantinuum’s Helios quantum computer to Oracle Cloud Infrastructure (OCI). OCI customers will get managed access via an OCI quantum service alongside HPC and GPU resources. Oracle plans to preview the service in coming months. Helios is a 98-qubit trapped-ion system launched in Nov 2025.

$ORCLMed

Quantinuum, Oracle agree multi-year quantum computing deal

Quantinuum and Oracle announced a multi-year partnership to deploy Quantinuum’s Helios quantum computer inside Oracle Cloud Infrastructure. Helios will be offered as an OCI quantum service in a US AI data center, with a preview expected in coming months. Quantinuum says Helios has 98 physical qubits and 99.921% average two-qubit gate fidelity. Quantinuum raised $1.68bn in its June IPO.

$QNTMedAI 8/10

Quantinuum: Q2 Earnings Snapshot

Quantinuum Inc (QNT) reported a Q2 loss of $65.4 million, or $1.93 per share. Adjusted losses were 28 cents per share versus a Zacks-estimated 26 cents. Revenue was $8 million. The company forecast full-year revenue of $28 million to $32 million.

$QNTHighAI 9/10

[QNT Q2 2026 Earnings Call] Quantinuum Ups Guidance to $32M, Bookings Surge Past $81M in Post-IPO Debut — BigGo Finance

Quantinuum (QNT) reported Q2 FY2026 revenue of $8M, up 279% year over year, and raised its 2026 revenue outlook to $28M to $32M. The company cited bookings of about $81M year to date, driven by a multi-year Oracle deal to deploy its Helios system in U.S. OCI data centers. It also discussed Sol validation and quantum error-correction milestones.